Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Longeveron Completes Enrollment for Alzheimer's Disease Study

americanpharmaceuticalreviewDecember 24, 2019

Tag: Longeveron , Alzheimer , LMSC

PharmaSources Customer Service